Aurobindo Pharma gets nod for seizure drug

18306 Investors following Aurobindo Pharm. Share this News with them.

0

Like this story, share it with millions of investors on M3

Aurobindo Pharma gets nod for seizure drug

Aurobindo Pharma Ltd said on Monday it got approval for its abbreviated new drug submission for topiramate tablets from Health Canada.

Post your opinion here

 

0

Tweet

Share on Tumblr

ALSO READ See latest News about Aurobindo Pharm See previous management interviews See what other Experts & Brokerages are saying about Aurobindo Pharm Aurobindo Pharm BSE | NSE 21/02/12 Are Mutual Funds betting on Aurobindo Pharm?

Aurobindo Pharma Ltd said on Monday it got approval for its abbreviated new drug submission for topiramate tablets from Health Canada.

Topiramate tablet is the generic equivalent of Canadian firm Janssen-Ortho Inc's Tapomax tablets, it said in a statement to the BSE.

Topiramate tablets are indicated as adjunctive therapy for patients with partial onset seizures and falls under the central nervous system therapeutic category, it added.